GC discussing some of the plans for this continue
Post# of 30027
(Total Views: 470)
Posted On: 03/03/2022 9:59:58 AM
GC discussing some of the plans for this continue on twitter:
“Absolutely Tollovir is targeting hospitalized under EUA, that has not changed. We are looking at plans to get Tollovid as an OTC drug label product. This was part of our plans, it is timely now so I mention it. We will outline full development plans after we announce 3CL closing”
https://twitter.com/g_commish/status/14993871...03594?s=21
Foggy asked if FDA approval is still on the table - I wonder this as well, but do like everything else I’m hearing. Let’s get it done !
“Absolutely Tollovir is targeting hospitalized under EUA, that has not changed. We are looking at plans to get Tollovid as an OTC drug label product. This was part of our plans, it is timely now so I mention it. We will outline full development plans after we announce 3CL closing”
https://twitter.com/g_commish/status/14993871...03594?s=21
Foggy asked if FDA approval is still on the table - I wonder this as well, but do like everything else I’m hearing. Let’s get it done !
(1)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼